Articles |
 Page 1 of 2  |
MedImmune strikes deal with Elusys.(Elusys Therapeutics Inc.)(licensin...
April 24, 2006
|
Launch of European biogeneric imminent.(Sandoz GmbH plans to launch Eu...
April 24, 2006
|
Dynavax advances early stage pipeline with $50m.(Dynavax Technologies ...
April 24, 2006
|
CVT gets line of credit for up to $200m.(Thursday, April 20)(Brief art...
April 24, 2006
|
Genzyme's first-quarter sales below expectations.(Genzyme Corp.)(Brief...
April 24, 2006
|
Novartis files for approval of Rasilez.(Friday, April 21)
April 24, 2006
|
Sirtris raises $37m in Series C fund raising.(Friday, April 21)
April 24, 2006
|
Labopharm files for $76m IPO on Nasdaq.(Thursday, April 20)
April 24, 2006
|
Good Phase II results for CRx-170 asthma drug.(Wednesday, April 19)
April 24, 2006
|
Benitec reduces work force to push RNAi work.(Wednesday, April 19)
April 24, 2006
|
FermaVir's antiviral portfolio to start testing.(Tuesday, April 18)
April 24, 2006
|
PharmaFrontiers gets $23m for MS compound.(Tuesday, April 18)
April 24, 2006
|
DiaDexus spins out CFD with therapeutics focus.(Monday, April 17)
April 24, 2006
|
BioFuels gain support with cheaper enzymes.(Monday, April 17)
April 24, 2006
|
YM gains subsidiary via Eximias acquisition.(Monday, April 17)
April 24, 2006
|
Vivitrol cleared for alcoholism treatment.(Monday, April 17)
April 24, 2006
|
Studying receptor function yielding targets for disease.(News From The...
April 24, 2006
|
New financing vehicles grow in popularity.(Brief article)
April 17, 2006
|
Research imperative: access vs. innovation.(health care costs and elde...
April 17, 2006
|
Flexibility key to seal deals, negotiators say.(Johnson & Johnson and ...
April 17, 2006
|
Mutations seen as neurodegenerative.(research on mutations in potassiu...
April 17, 2006
|
Start-up Cempra secures antibacterial program.(Friday, April 14)
April 17, 2006
|
MGI submits NDA for Saforis.(Friday, April 14)
April 17, 2006
|
Gilead invests $25m in Corus Pharma.(Friday, April 14)
April 17, 2006
|
Renovis CEO: beware of short sellers' influence.(Thursday, April 13)
April 17, 2006
|
Non-embryonic stem cell work moving forward.(Thursday, April 13)
April 17, 2006
|
CNS firms Vanda, Targacept price IPOs.(Thursday, April 13)
April 17, 2006
|
Infinity gains listing through merger.(Thursday, April 13)
April 17, 2006
|
Clinton: genetically enhanced crops essential.(Wednesday, April 12)
April 17, 2006
|
Xenon set to enter clinic with $31m financing.(Wednesday, April 12)
April 17, 2006
|
Start-up firm Proprius licenses topical NSAID.(Wednesday, April 12)
April 17, 2006
|
Japan making biotechnology push.(Wednesday, April 12)
April 17, 2006
|
Getting Biotech means outbidding others.(Tuesday, April 11)
April 17, 2006
|
Corautus halts Phase II enrollment; stock drops.(Tuesday, April 11)
April 17, 2006
|
Medarex raises $112m for R&D, clinical work.(Monday, April 10)
April 17, 2006
|
Biotech execs ask for BioShield reform.(Monday, April 10)
April 17, 2006
|
Cougar merges into shell, raises $47m.(Monday, April 10)
April 17, 2006
|
Bidding war ends with Pfizer taking over Rinat.(Monday, April 10)
April 17, 2006
|
Pharmacyclics buys Celera Drugs for up to $150m.(Celera Genomics Group...
April 17, 2006
|
Merrimack's Series E: $65m for autoimmune.(Merrimack Pharmaceuticals I...
April 10, 2006
|
FDA holds up Cortex's CX717.(Food and Drug Administration)(Cortex Phar...
April 10, 2006
|
EPIX Pharma buying Predix for $90m.(Tuesday, April 4)
April 10, 2006
|
Sirna, GSK enter respiratory deal.(Tuesday, April 4)
April 10, 2006
|
Veronate data crush Inhibitex.(Tuesday, April 4)
April 10, 2006
|
Medarex begins second pivotal study of MDX-010.(Monday, April 3)
April 10, 2006
|
Cardiome, Astellas file NDA for RSD1235 in AF.(Monday, April 3)
April 10, 2006
|
NitroMed cuts back R&D to ready for BiDil sales.(Monday, April 3)
April 10, 2006
|
Cancer drug developers running out of excuses.(News From The Lab)
April 10, 2006
|
Biogen sells Amevive rights to Astellas for $60m.
April 10, 2006
|
Aastrom raises $25m for stem Cell technology.(Friday, April 7)
April 10, 2006
|
Replidyne files IPO for up to $100m.(Friday, April 7)
April 10, 2006
|
Tapestry collects $25m for anticancer drug.(Friday, April 7)
April 10, 2006
|
TGN1412 finding points to cytokine reaction.(Thursday, April 5)
April 10, 2006
|
Discovery labs gets approvable letter.(Thursday, April 5)
April 10, 2006
|
Nabi licenses rights for Fresenius drug.(Wednesday, April 5)
April 10, 2006
|
The Medicines Co. starts Phase III for anticoagulant.(Wednesday, April...
April 10, 2006
|
QLT, Retinagenix partner on synthetic retinoid.(Thursday, April 5)(Ret...
April 10, 2006
|
Corgentech's Phase II VR1 agonist study negative.(non-opioid pain drug...
April 03, 2006
|
Acadia preparing for ACP-103 trial.(Acadia Pharmaceuticals Inc)(Brief ...
April 03, 2006
|
Clinical Data begins depression drug study.(Friday, March 31)
April 03, 2006
|
Amylin adding $465m via public stock sale.(Friday, March 31)
April 03, 2006
|
Amgen, Abgenix finish BLA for panitumumab.(Friday, March 31)
April 03, 2006
|
Pharmacopeia, GSK form unique partnership.(Friday, March 31)
April 03, 2006
|
Diagnostics seen as future of health care.(Wednesday, March 29)
April 03, 2006
|
Arteriocyte's focus: stem cells for ischemic repair.(Thursday, March 3...
April 03, 2006
|
Dynavax buys Rhein Biotech for $12m cash.(Wednesday, March 29)
April 03, 2006
|
Sequenom raises $30m for genetic analysis.(Wednesday, March 29)
April 03, 2006
|
SGX, Novartis sign $515m deal for CML compounds.(Wednesday, March 29)
April 03, 2006
|
RNAi data lead to Alnylam/INEX deal.(Tuesday, March 28)
April 03, 2006
|
Encysive shares tumble on FDA notification.(Tuesday, March 28)
April 03, 2006
|
BioMarin raising $267m via share, note offerings.(Monday, March 27)
April 03, 2006
|
Idenix drops on dose change in phase IIb trials.(Monday, March 27)
April 03, 2006
|
Keryx pads balance sheet with $83m stock sale.(Tuesday, March 28)
April 03, 2006
|
Antigenics' Oncophage misses in phase III trial.(Monday, March 27)
April 03, 2006
|
Cancer immunity and the antibody's Fc region.(News From The Lab)
April 03, 2006
|
| More
articles from BioWorld Week... |
